Asthma Risk and Ultra-processed Foods
High consumption of ultra-processed food products significantly raises the likelihood of asthma onset in school-age children, according to a longitudinal study.
High consumption of ultra-processed food products significantly raises the likelihood of asthma onset in school-age children, according to a longitudinal study.
High consumption of ultra-processed food products significantly raises the likelihood of asthma onset in school-age children, according to a longitudinal study.
Read MoreThe American College of Allergy, Asthma and Immunology emphasizes the link between uncontrolled allergies and asthma flares.
Read MoreThe European Commission authorized the EURneffy 1 mg nasal spray for pediatric patients who weigh between 15 and 30 kg and are at risk of severe allergic reactions.
Read MoreThe updated label for the Neffy 1 mg dose allows children weighing at least 33 pounds to access the needle-free treatment regardless of age.
Read MoreThe most engaging allergy/immunology social media content is often the least accurate, especially those around natural remedies and IgG testing.
Read MoreA mold reduction initiative in New York City resulted in 2,798 fewer emergency department visits per year for asthma exacerbation.
Read MoreThe European Medicines Agency’s CHMP recommended expanding the marketing authorization for EURneffy to include a 1 mg dose.
Read MoreCalifornia K-12 schools are now eligible for the neffyinSchools program, providing needle-free nasal spray epinephrine at no cost for emergency use.
Read MoreA 30 mg peanut oral immunotherapy maintenance dose improved peanut tolerance to a similar extent as a higher 300 mg dose, while being associated with fewer systemic adverse events.
Read MoreThe National Medical Products Administration (NMPA) in China granted approval for neffy 2 mg (epinephrine nasal spray) for the emergency treatment of Type 1 allergic reactions in adults and children weighing 30 kg or more.
Read MoreA Phase III NATRON trial found Fasenra (benralizumab) had benefits for patients with hypereosinophilic syndrome (HES).
Read MorePatients with allergic conditions—including eczema, asthma, and hay fever—may face more problems after certain types of surgery, according to research at ACAAI 2025.
Read MoreResearch uncovered a reluctance among obstetricians to refer their pregnant patients to allergy specialists, even when a referral could help improve care.
Read MoreSocial media platforms give allergy and asthma patients a voice but they also amplify misinformation, and the most popular posts are often not the most accurate.
Read MoreOral immunotherapy and oral food challenges (OFCs) are both safe for young patients and can be life-changing for families navigating food allergies.
Read MoreCOVID-19 vaccinated children had significantly fewer infections, including pneumonia, bronchitis, bronchiolitis, sinusitis, upper respiratory infections, and more.
Read MoreThe Teal Pumpkin Project is hoping to provide an allergy-free Halloween to children across the United States who suffer from food allergies.
Read MoreA Univ of Michigan study found suicide deaths jumped as much as 7.4% in high pollen seasons, suggesting the physical discomfort of allergies may trigger a deeper, more dangerous despair, an overlooked factor in suicide prevention.
Read MoreInfant exposure to dog allergens, but not cat allergens, was associated with reduced incidence of child asthma.
Read MoreRegulators in Japan have cleared neffy epinephrine nasal spray for emergency use in adults and children for life-threatening allergies.
Read MoreNew data indicates nearly 90% of patients experiencing anaphylaxis symptoms were successfully treated with a single dose of neffy nasal spray.
Read MoreThe UK MHRA has authorized EURneffy for the emergency treatment of anaphylaxis in adults and children weighing 30kg or more.
Read MorePatients ceasing long-term use of oral allergy medications cetirizine (Zyrtec) or levocetirizine (Xyzal) may experience rare but severe itching called pruritus, according to an FDA alert.
Read MoreNeffy epinephrine nasal spray 1 mg is now available by prescription in the US for the treatment of Type I allergic reactions, including anaphylaxis, in pediatric patients weighing 15 kg to <30 kg.
Read More